Pei, X., Huang, Q., Luo, L., Sun, H., Liu, J., Sun, Y., . . . Huang, X. (2024). Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation. Haematologica, 999(1), . https://doi.org/10.3324/haematol.2024.286265
Chicago-referens (17:e uppl.)Pei, Xu-Ying, et al. "Letermovir Prophylaxis for Cytomegalovirus Is Associated with Risk of Post-transplant Lymphoproliferative Disorders After Haploidentical Stem Cell Transplantation." Haematologica 999, no. 1 (2024). https://doi.org/10.3324/haematol.2024.286265.
MLA-referens (9:e uppl.)Pei, Xu-Ying, et al. "Letermovir Prophylaxis for Cytomegalovirus Is Associated with Risk of Post-transplant Lymphoproliferative Disorders After Haploidentical Stem Cell Transplantation." Haematologica, vol. 999, no. 1, 2024, https://doi.org/10.3324/haematol.2024.286265.
